Selected research
Industry Research
β-Tricalcium Phosphate for Surgical Implantation Industry Research Report 2026
Market perspective
The global β-Tricalcium Phosphate for Surgical Implantation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for β-Tricalcium Phosphate for Surgical Implantation is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for β-Tricalcium Phosphate for Surgical Implantation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for β-Tricalcium Phosphate for Surgical Implantation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of β-Tricalcium Phosphate for Surgical Implantation include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global β-Tricalcium Phosphate for Surgical Implantation market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to β-Tricalcium Phosphate for Surgical Implantation.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
β-Tricalcium Phosphate for Surgical Implantation Market by Company
Berkeley Advanced Biomaterials
CaP Biomaterials
Fluidinova
ICL Performance Products
Innophos
Suzhou Dingan Technology
Shanghai Bio-lu Biomaterials
Kunshan Chinese Technology New Materiais
Beijing Deke Daojin Science and Technology
SigmaGraft Biomaterials
Plasma Biotal
NEI
Merz North America
β-Tricalcium Phosphate for Surgical Implantation Segment by Type
Spherical
Amorphous
β-Tricalcium Phosphate for Surgical Implantation Segment by Application
Dentistry
Orthopaedics
Others
β-Tricalcium Phosphate for Surgical Implantation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global β-Tricalcium Phosphate for Surgical Implantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of β-Tricalcium Phosphate for Surgical Implantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of β-Tricalcium Phosphate for Surgical Implantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of β-Tricalcium Phosphate for Surgical Implantation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of β-Tricalcium Phosphate for Surgical Implantation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of β-Tricalcium Phosphate for Surgical Implantation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spherical
- Amorphous
Applications
- Dentistry
- Orthopaedics
- Others
Companies covered
- Berkeley Advanced Biomaterials
- CaP Biomaterials
- Fluidinova
- ICL Performance Products
- Innophos
- Suzhou Dingan Technology
- Shanghai Bio-lu Biomaterials
- Kunshan Chinese Technology New Materiais
- Beijing Deke Daojin Science and Technology
- SigmaGraft Biomaterials
- Plasma Biotal
- NEI
- Merz North America
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 β-Tricalcium Phosphate for Surgical Implantation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Spherical
- 2.2.3 Amorphous
- 2.3 β-Tricalcium Phosphate for Surgical Implantation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dentistry
- 2.3.3 Orthopaedics
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global β-Tricalcium Phosphate for Surgical Implantation Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global β-Tricalcium Phosphate for Surgical Implantation Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global β-Tricalcium Phosphate for Surgical Implantation Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global β-Tricalcium Phosphate for Surgical Implantation Production by Manufacturers (2021-2026)
- 3.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Manufacturers (2021-2026)
- 3.3 Global β-Tricalcium Phosphate for Surgical Implantation Average Price by Manufacturers (2021-2026)
- 3.4 Global β-Tricalcium Phosphate for Surgical Implantation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global β-Tricalcium Phosphate for Surgical Implantation Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global β-Tricalcium Phosphate for Surgical Implantation Manufacturers, Product Type & Application
- 3.7 Global β-Tricalcium Phosphate for Surgical Implantation Manufacturers Established Date
- 3.8 Global β-Tricalcium Phosphate for Surgical Implantation Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Berkeley Advanced Biomaterials
- 4.1.1 Berkeley Advanced Biomaterials β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.1.2 Berkeley Advanced Biomaterials β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.1.3 Berkeley Advanced Biomaterials β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Berkeley Advanced Biomaterials Product Portfolio
- 4.1.5 Berkeley Advanced Biomaterials Recent Developments
- 4.2 CaP Biomaterials
- 4.2.1 CaP Biomaterials β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.2.2 CaP Biomaterials β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.2.3 CaP Biomaterials β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 CaP Biomaterials Product Portfolio
- 4.2.5 CaP Biomaterials Recent Developments
- 4.3 Fluidinova
- 4.3.1 Fluidinova β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.3.2 Fluidinova β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.3.3 Fluidinova β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Fluidinova Product Portfolio
- 4.3.5 Fluidinova Recent Developments
- 4.4 ICL Performance Products
- 4.4.1 ICL Performance Products β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.4.2 ICL Performance Products β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.4.3 ICL Performance Products β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 ICL Performance Products Product Portfolio
- 4.4.5 ICL Performance Products Recent Developments
- 4.5 Innophos
- 4.5.1 Innophos β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.5.2 Innophos β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.5.3 Innophos β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Innophos Product Portfolio
- 4.5.5 Innophos Recent Developments
- 4.6 Suzhou Dingan Technology
- 4.6.1 Suzhou Dingan Technology β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.6.2 Suzhou Dingan Technology β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.6.3 Suzhou Dingan Technology β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Suzhou Dingan Technology Product Portfolio
- 4.6.5 Suzhou Dingan Technology Recent Developments
- 4.7 Shanghai Bio-lu Biomaterials
- 4.7.1 Shanghai Bio-lu Biomaterials β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.7.2 Shanghai Bio-lu Biomaterials β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.7.3 Shanghai Bio-lu Biomaterials β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Shanghai Bio-lu Biomaterials Product Portfolio
- 4.7.5 Shanghai Bio-lu Biomaterials Recent Developments
- 4.8 Kunshan Chinese Technology New Materiais
- 4.8.1 Kunshan Chinese Technology New Materiais β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.8.2 Kunshan Chinese Technology New Materiais β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.8.3 Kunshan Chinese Technology New Materiais β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Kunshan Chinese Technology New Materiais Product Portfolio
- 4.8.5 Kunshan Chinese Technology New Materiais Recent Developments
- 4.9 Beijing Deke Daojin Science and Technology
- 4.9.1 Beijing Deke Daojin Science and Technology β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.9.2 Beijing Deke Daojin Science and Technology β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.9.3 Beijing Deke Daojin Science and Technology β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Beijing Deke Daojin Science and Technology Product Portfolio
- 4.9.5 Beijing Deke Daojin Science and Technology Recent Developments
- 4.10 SigmaGraft Biomaterials
- 4.10.1 SigmaGraft Biomaterials β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.10.2 SigmaGraft Biomaterials β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.10.3 SigmaGraft Biomaterials β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 SigmaGraft Biomaterials Product Portfolio
- 4.10.5 SigmaGraft Biomaterials Recent Developments
- 4.11 Plasma Biotal
- 4.11.1 Plasma Biotal β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.11.2 Plasma Biotal β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.11.3 Plasma Biotal β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Plasma Biotal Product Portfolio
- 4.11.5 Plasma Biotal Recent Developments
- 4.12 NEI
- 4.12.1 NEI β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.12.2 NEI β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.12.3 NEI β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 NEI Product Portfolio
- 4.12.5 NEI Recent Developments
- 4.13 Merz North America
- 4.13.1 Merz North America β-Tricalcium Phosphate for Surgical Implantation Company Information
- 4.13.2 Merz North America β-Tricalcium Phosphate for Surgical Implantation Business Overview
- 4.13.3 Merz North America β-Tricalcium Phosphate for Surgical Implantation Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Merz North America Product Portfolio
- 4.13.5 Merz North America Recent Developments
5 Global β-Tricalcium Phosphate for Surgical Implantation Production by Region
- 5.1 Global β-Tricalcium Phosphate for Surgical Implantation Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global β-Tricalcium Phosphate for Surgical Implantation Production by Region: 2021-2032
- 5.2.1 Global β-Tricalcium Phosphate for Surgical Implantation Production by Region: 2021-2026
- 5.2.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Forecast by Region (2027-2032)
- 5.3 Global β-Tricalcium Phosphate for Surgical Implantation Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Region: 2021-2032
- 5.4.1 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Region: 2021-2026
- 5.4.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Value Forecast by Region (2027-2032)
- 5.5 Global β-Tricalcium Phosphate for Surgical Implantation Market Price Analysis by Region (2021-2026)
- 5.6 Global β-Tricalcium Phosphate for Surgical Implantation Production and Value, YOY Growth
- 5.6.1 North America β-Tricalcium Phosphate for Surgical Implantation Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe β-Tricalcium Phosphate for Surgical Implantation Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China β-Tricalcium Phosphate for Surgical Implantation Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan β-Tricalcium Phosphate for Surgical Implantation Production Value Estimates and Forecasts (2021-2032)
6 Global β-Tricalcium Phosphate for Surgical Implantation Consumption by Region
- 6.1 Global β-Tricalcium Phosphate for Surgical Implantation Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global β-Tricalcium Phosphate for Surgical Implantation Consumption by Region (2021-2032)
- 6.2.1 Global β-Tricalcium Phosphate for Surgical Implantation Consumption by Region: 2021-2026
- 6.2.2 Global β-Tricalcium Phosphate for Surgical Implantation Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America β-Tricalcium Phosphate for Surgical Implantation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America β-Tricalcium Phosphate for Surgical Implantation Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe β-Tricalcium Phosphate for Surgical Implantation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe β-Tricalcium Phosphate for Surgical Implantation Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific β-Tricalcium Phosphate for Surgical Implantation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific β-Tricalcium Phosphate for Surgical Implantation Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa β-Tricalcium Phosphate for Surgical Implantation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa β-Tricalcium Phosphate for Surgical Implantation Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global β-Tricalcium Phosphate for Surgical Implantation Production by Type (2021-2032)
- 7.1.1 Global β-Tricalcium Phosphate for Surgical Implantation Production by Type (2021-2032) & (Tons)
- 7.1.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Market Share by Type (2021-2032)
- 7.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Type (2021-2032)
- 7.2.1 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Value Market Share by Type (2021-2032)
- 7.3 Global β-Tricalcium Phosphate for Surgical Implantation Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global β-Tricalcium Phosphate for Surgical Implantation Production by Application (2021-2032)
- 8.1.1 Global β-Tricalcium Phosphate for Surgical Implantation Production by Application (2021-2032) & (Tons)
- 8.1.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Market Share by Application (2021-2032)
- 8.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Application (2021-2032)
- 8.2.1 Global β-Tricalcium Phosphate for Surgical Implantation Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global β-Tricalcium Phosphate for Surgical Implantation Production Value Market Share by Application (2021-2032)
- 8.3 Global β-Tricalcium Phosphate for Surgical Implantation Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 β-Tricalcium Phosphate for Surgical Implantation Value Chain Analysis
- 9.1.1 β-Tricalcium Phosphate for Surgical Implantation Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 β-Tricalcium Phosphate for Surgical Implantation Production Mode & Process
- 9.2 β-Tricalcium Phosphate for Surgical Implantation Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 β-Tricalcium Phosphate for Surgical Implantation Distributors
- 9.2.3 β-Tricalcium Phosphate for Surgical Implantation Customers
10 Global β-Tricalcium Phosphate for Surgical Implantation Analyzing Market Dynamics
- 10.1 β-Tricalcium Phosphate for Surgical Implantation Industry Trends
- 10.2 β-Tricalcium Phosphate for Surgical Implantation Industry Drivers
- 10.3 β-Tricalcium Phosphate for Surgical Implantation Industry Opportunities and Challenges
- 10.4 β-Tricalcium Phosphate for Surgical Implantation Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst